Search research articles
Contact Us
Filters
Showing results (391-400 of 455) with videos related to
Page
of 46
Sort By:
Molecular Cancer
|
June 3, 2014
Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway
Xin Xu, Jian Wu, Shiqi Li, et al.
Cell Death Discovery
|
November 23, 2021
circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis
Xueyou Ma, Yufan Ying, Jiazhu Sun, et al.
Molecules and Cells
|
January 6, 2015
MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1
Zhen Liang, Shiqi Li, Xin Xu, et al.
World Journal of Surgical Oncology
|
December 30, 2024
Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study
Xuan Shu, Jiaming Wang, Wen Cai, et al.
Hepatology (Baltimore, Md.)
|
March 29, 2020
Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway
Shuang Zhao, Tianyu Song, Yue Gu, et al.
Acta Medica Okayama
|
November 1, 2011
Single nucleotide polymorphism WRN Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects
Lei Wang, Haruki Kaku, Peng Huang, et al.
Frontiers in Endocrinology
|
February 23, 2024
Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial
Meifang Liu, Yuan Ming Di, Lei Zhang, et al.
Antioxidants & Redox Signaling
|
May 25, 2017
Hydrogen Sulfide As a Potential Target in Preventing Spermatogenic Failure and Testicular Dysfunction
Jing Wang, Wan Wang, Shuangyue Li, et al.
Cell Death Discovery
|
August 12, 2022
FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m<sup>6</sup>A dependent pathway
Haixiang Shen, Yufan Ying, Xueyou Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia
Gang An, Daobin Zhou, Shu Cheng, et al.
Page
of 46
Search research articles
Search
Showing results (391-400 of 455) with videos related to
Sort By:
Page
of 46
Molecular Cancer
|
June 3, 2014
Downregulation of microRNA-182-5p contributes to renal cell carcinoma proliferation via activating the AKT/FOXO3a signaling pathway
Xin Xu, Jian Wu, Shiqi Li, et al.
Cell Death Discovery
|
November 23, 2021
circKDM4C enhances bladder cancer invasion and metastasis through miR-200bc-3p/ZEB1 axis
Xueyou Ma, Yufan Ying, Jiazhu Sun, et al.
Molecules and Cells
|
January 6, 2015
MicroRNA-576-3p inhibits proliferation in bladder cancer cells by targeting cyclin D1
Zhen Liang, Shiqi Li, Xin Xu, et al.
World Journal of Surgical Oncology
|
December 30, 2024
Clinical assessment of urinary prostate cancer antigen 3 in Chinese population: a large-scale, prospective and multicenter study
Xuan Shu, Jiaming Wang, Wen Cai, et al.
Hepatology (Baltimore, Md.)
|
March 29, 2020
Hydrogen Sulfide Alleviates Liver Injury Through the S-Sulfhydrated-Kelch-Like ECH-Associated Protein 1/Nuclear Erythroid 2-Related Factor 2/Low-Density Lipoprotein Receptor-Related Protein 1 Pathway
Shuang Zhao, Tianyu Song, Yue Gu, et al.
Acta Medica Okayama
|
November 1, 2011
Single nucleotide polymorphism WRN Leu1074Phe is associated with prostate cancer susceptibility in Chinese subjects
Lei Wang, Haruki Kaku, Peng Huang, et al.
Frontiers in Endocrinology
|
February 23, 2024
Oral Chinese Herbal Medicine plus usual care for diabetic kidney disease: study protocol for a randomized, double-blind, placebo-controlled pilot trial
Meifang Liu, Yuan Ming Di, Lei Zhang, et al.
Antioxidants & Redox Signaling
|
May 25, 2017
Hydrogen Sulfide As a Potential Target in Preventing Spermatogenic Failure and Testicular Dysfunction
Jing Wang, Wan Wang, Shuangyue Li, et al.
Cell Death Discovery
|
August 12, 2022
FTO promotes clear cell renal cell carcinoma progression via upregulation of PDK1 through an m<sup>6</sup>A dependent pathway
Haixiang Shen, Yufan Ying, Xueyou Ma, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
July 13, 2021
A Phase II Trial of the Bruton Tyrosine-Kinase Inhibitor Zanubrutinib (BGB-3111) in Patients with Relapsed/Refractory Waldenström Macroglobulinemia
Gang An, Daobin Zhou, Shu Cheng, et al.
Page
of 46